Satish Poondi is an associate and a member of the Mass Tort/Class Action Team. Mr. Poondi is also a registered pharmacist, having received his Doctor of Pharmacy degree from Rutgers University. Mr. Poondi's unique combination of knowledge and experience in law and science allows him to provide his clients with the most comprehensive approach to the issues they face, creating strategies that address both the legal and business aspects of each matter.
Mr. Poondi's clients represent all sectors of the pharmacy industry, including: independent pharmacies, pharmacists, pharmacy technicians, retail chains, wholesalers, hospitals, and compounding pharmacies. He represents healthcare professionals, as well as third party insurance companies, before licensing boards, including: the New Jersey Board of Pharmacy, New Jersey Medicaid, Medicare, the Drug Enforcement Administration and the Office for Civil Rights. He routinely provides guidance on the regulatory requirements associated with the sale and purchase of pharmacies. In addition, Mr. Poondi provides advice and counsel on the following to his clients:
•Medicaid/third party audits
•Defense against Medicaid/Medicare fraud charges
•DEA regulatory compliance/hearings
•Mail order pharmacies
Mr. Poondi remains active in pharmacy academia. He is a guest lecturer at the Ernest Mario School of Pharmacy at Rutgers University and serves as an advisor to multiple pharmacy organizations. Mr. Poondi understands the importance of educating lawyers and healthcare providers alike by regularly lecturing at continuing education seminars and programs sponsored by academic institutions, professional organizations and retail chains on relevant, topical pharmaceutical legal issues. In addition to his administrative law practice, Mr. Poondi also advocates for patients injured by defective products against large pharmaceutical companies. He also represents clients with lung cancer and mesothelioma caused by their exposure to asbestos. Some of his most recent matters include:
•Victims of bladder cancer who were prescribed and took Actos, a diabetes medication
•Heart attack and stroke victims who were prescribed and took Avandia, a diabetes medication
•Patients who developed gastrointestinal complications, such as ulcerative colitis, after taking Accutane, a medication used to treat acne
•Patients that suffered from psychotic episodes after taking a generic version of Wellbutrin XL, a drug recalled by the FDA
•Patients that lost limbs after being administered Heparin, an anti-coagulant
Mr. Poondi is a member of the firm's Cyber State Legal Resource Group. In that capacity, he consults with pharmacies and other healthcare providers on a variety of issues relating to the transmission and receipt of patient records, including: developing policy manuals, drafting privacy notices and related documents, conducting employee training regarding HIPAA compliance and data sharing, regulatory filing requirements and business associate agreements related to Medication Therapy Management.
Mr. Poondi is also an active member of the community. He is the Director of Legislative Affairs for the Asian American Retailers Association and Director of Communications for the Indian Business Association. He previously served on the Mayor's Advisory Committee on Community Relations for the township of Edison. In addition, Mr. Poondi is on the Executive Board of various Middlesex County based community associations.
Area of Emphasis:
Defective Drug Litigation
Toxic Tort Class Action Litigation
Miscellaneous Toxic Tort Litigation
Pharmacy Administrative Law
•Dealing With Medicare & Medicaid
•NJ Board of Pharmacy - How to Deal with Various Licensing Issues You May Encounter
•The Anatomy of a DEA Case - Your Rights, Responsibilities, & Potential Liabilities
•New Jersey Healthcare Regulatory Update - April 2014